Faculty Biography

John Fanikos, M.B.A., R.Ph.
Assistant Director of Pharmacy
Brigham and Women’s Hospital
Assistant Professor of Clinical Pharmacy
Northeastern University
Massachusetts College of Pharmacy
Boston, Massachusetts

John Fanikos, M.B.A., R.Ph. is the Assistant Director of Pharmacy at Brigham and Women's Hospital (BWH) in Boston, Massachusetts. He is also an Assistant Professor of Clinical Pharmacy Practice at both Northeastern University and the Massachusetts College of Pharmacy, where he earned his Bachelor of Science degree in pharmacy. He completed an American Society of Health-System Pharmacists (ASHP) accredited residency at BWH and earned his Master of Business Administration degree from Northeastern University. He is a member of several professional societies, including ASHP, the Massachusetts Society of Health-System Pharmacists, and the New England Council of Hospital Pharmacists. Mr. Fanikos currently chairs the Voluntary Hospital Association (VHA) Northeast States Clinical Pharmacy Council. He has served in a number of different roles at BWH, including investigational drug pharmacist, inpatient and outpatient pharmacy supervisor, clinical preceptor, and pharmacy administrator. During his pharmacy practice, Mr. Fanikos has worked with orthopedic, oncology, cardiology, and general medicine patients. Over the past ten years, he has worked closely with the BWH Venous Thromboembolism Service and authored/co-authored many articles on the complications of anticoagulation therapy. 

Disclosure Information

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, ASHP Advantage requires that all faculty members involved in the development of program content to disclose their relevant financial relationships.  A faculty member has a relevant financial relationship if the individual or his or her spouse/partner has a financial relationship (e.g., employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring in the last 12 months with a commercial interest whose products or services may be discussed in the CME activity content over which the faculty member has control.  The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on faculty presentations.

Mr. Fanikos reports that he has served on the speakers bureau for Eisai Pharmaceuticals, GlaxoSmithKline, sanofi-aventis, Schering, and Genentech.